Skip to main content
. 2016 Mar 5;81(5):958–970. doi: 10.1111/bcp.12834

Figure 2.

Figure 2

Longitudinal plots of mean fold‐change in levels of vascular endothelial growth factor D (VEGF‐D), collagen type IV (COL‐IV), vascular endothelial growth factor A (VEGF‐A) and soluble VEGF receptor 2 (VEGFR2) over time. (Inline graphic) everolimus, (Inline graphic) placebo